Use of chromogenic assay of factor X to accept or reject INR results in warfarin treated patients

Clinical Medicine and Research

Volumn 7, Issue 3, 2009, Pages 103-105

  Sanfelippo, Michael J ^a   Zinsmaster, Wendy ^a   Scherr, Doris L ^a   Shaw, Gene R ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

Factor X; International normalized ratio (INR); Warfarin

Indexed keywords

BATROXOBIN; BLOOD CLOTTING FACTOR 10; CHROMOGENIC SUBSTRATE; FIBRIN; FIBRINOGEN; PROTHROMBIN; THROMBIN; WARFARIN;

ACCURACY; AGED; ANAMNESIS; AORTA VALVE REPLACEMENT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CONGESTIVE HEART FAILURE; DYSFIBRINOGENEMIA; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTRACARDIAC THROMBOSIS; LABORATORY TEST; LUNG CANCER; LUNG RESECTION; MEDICAL ASSESSMENT; PATIENT MONITORING; PROTHROMBIN TIME; THROMBIN TIME;

AGED; ANTICOAGULANTS; BLOOD COAGULATION; CHROMOGENIC COMPOUNDS; FACTOR X; FEMALE; FIBRIN; FIBRINOGEN; HEART FAILURE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LUNG NEOPLASMS; PROTHROMBIN TIME; TIME FACTORS; WARFARIN;

EID: 72549112124     PISSN: 15394182     EISSN: None     Source Type: Journal    
DOI: 10.3121/cmr.2009.836     Document Type: Article

References (4)

1. Sanfelippo MJ, Sennet J, McMahon EJ. Falsely elevated INRs in warfarin-treated patients with the lupus anticoagulant. WMJ 2000;99:62-64, 43.
2. Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann Intern Med 1997;127:177-185.
3. Hayes T. Dysfibrinogenemia and thrombosis. Arch Pathol Lab Med 2002;126:1387-1390.
4. Lefkowitz JB, DeBoom T, Weller A, Clarke S, Lavrinets D. Fibrinogen Longmont: a dysfibrinogenemia that causes prolonged clot-based test results only when using an optical detection method. Am J Hematol 2000;63:149-155. (Pubitemid 30120770)